Remimazolam Anxiety Dose-Finding Study Used a Specific Parent-Separation Endpoint

An ED90 estimate applies to a defined response and study population; it is not a universal effective dose.

What the supplied paper reports

Eighty children aged one to six completed a sequential dose-finding study, split into younger and older groups. Success meant a parent-separation anxiety score below three. Isotonic regression estimated the dose achieving that response in ninety percent of each study population, with different estimates across the two age groups.

What the findings cannot establish

The design estimates a target response probability rather than directly comparing all doses in a large parallel trial. Confidence intervals describe estimation uncertainty, and a threshold on this anxiety scale does not establish equivalent amnesia, procedural conditions or safety. Results concern intravenous administration in the studied perioperative setting.

Implications for forensic review

For pediatric review, state the endpoint before citing an effective-dose statistic. A child who remains distressed is not automatically evidence of dosing negligence, just as separation success does not prove readiness for a painful procedure. Examine age, assessment timing and subsequent respiratory and behavioral observations alongside the estimated population response.

Source and related reading

Source reviewed: ED90 of intravenous remimazolam for alleviating preoperative anxiety in children a prospective dose (PMC13036471). The forensic applications above are interpretive analysis of the supplied paper.